ASTL and pancreatic neoplasm: Because SAS1B localizes to the cell membrane in pancreatic cancer cells and previous data have shown that SAS1B is endocytosed [16], we hypothesized that these could be killed using an ADC targeting SAS1B, with varying degrees of cytotoxicity correlated to relative antigen level at the cell surface.